The natural history of latent rheumatic heart disease in a 5 year follow-up study: A prospective observational study

BMC Cardiovascular Disorders

Volumn 16, Issue 1, 2016, Pages

  Zühlke, Liesl ^a,b   Engel, Mark E ^a   Lemmer, Carolina E ^a   van de Wall, Marnie ^a   Nkepu, Simpiwe ^a   Meiring, Alet ^b,c   Bestawros, Michael ^a,d   Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Latent rheumatic heart disease; Natural history; Outcome

Indexed keywords

ADOLESCENT; ADULT; AORTA VALVE REGURGITATION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RHEUMATIC HEART DISEASE; AORTIC REGURGITATION; DIAGNOSTIC IMAGING; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEX DIFFERENCE; SOUTH AFRICA; YOUNG ADULT;

ADOLESCENT; AORTIC VALVE INSUFFICIENCY; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS; RHEUMATIC HEART DISEASE; SEX FACTORS; SOUTH AFRICA; YOUNG ADULT;

EID: 84959228687     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-016-0225-3     Document Type: Article

References (22)

1. Milne RJ, Lennon DR, Stewart JM, Vander Hoorn S, Scuffham PA. Incidence of acute rheumatic fever in New Zealand children and youth. J Paediatr Child Health. 2012;48(8):685-91.
2. Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Joachim A, Daniels R, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015;36(18):1115-22.
3. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990?2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2197-223.
4. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. The Lancet. 2012;379(9819):953-64.
5. Saxena A, Zühlke L, Wilson N. Echocardiographic screening for rheumatic heart disease. Global Heart. 2013;8:197-202.
6. Mayosi BM. The challenge of silent rheumatic heart disease. The Lancet Global health. 2014;2(12):e677-678.
7. Saxena A. Increasing detection of rheumatic heart disease with echocardiography. Expet Rev Med Dev. 2014;1-7.
8. Paar JA, Berrios NM, Rose JD, Cáceres M, Peña R, Pérez W, Chen-Mok M, Jolles E, Dale JB. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010;105(12):1809-14.
9. Bhaya M, Beniwal R, Panwar S, Panwar RB. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography. 2011;28(9):929-33.
10. Saxena A, Ramakrishnan S, Roy A, Seth S, Krishnan A, Misra P, Kalaivani M, Bhargava B, Flather MD, Poole-Wilson PPA. Prevalence and outcome of subclinical rheumatic heart disease in India: The RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart. 2011;97(24):2018-22.
11. Beaton A, Okello E, Aliku T, Lubega S, Lwabi P, Mondo C, McCarter R, Sable C. Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection. Pediatr Cardiol. 2014;35(7):1259-67.
12. Mirabel M, Celermajer DS, Ferreira B, Tafflet M, Perier MC, Karam N, Mocumbi AO, Jani DN, Sidi D, Jouven X, et al. Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. Eur Heart J Cardiovasc Imaging. 2012;13:1024-9.
13. Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease - an evidence-based guideline. Nat Rev Cardiol. 2012;9(5):297-309.
14. Weinberg J, Beaton A, Aliku T, Lwabi P, Sable C. Prevalence of rheumatic heart disease in African school-aged population: Extrapolation from echocardiography screening using the 2012 World Heart Federation Guidelines. Int J Cardiol. 2012;2015(202):238-9.
15. Mirabel M, Fauchier T, Bacquelin R, Tafflet M, Germain A, Robillard C, Rouchon B, Marijon E, Jouven X. Echocardiography screening to detect rheumatic heart disease: A cohort study of schoolchildren in French Pacific Islands. Int J Cardiol. 2015;188:89-95.
16. Otto H, Saether SG, Banteyrga L, Haugen BO, Skjaerpe T. High prevalence of subclinical rheumatic heart disease in pregnant women in a developing country: an echocardiographic study. Echocardiography. 2011;28(10):1049-53.
17. Kane A, Mirabel M, Toure K, Perier MC, Fazaa S, Tafflet M, Karam N, Zourak I, Diagne D, Mbaye A, et al. Echocardiographic screening for rheumatic heart disease: age matters. Int J Cardiol. 2013;168(2):888-91.
18. Zhimin W, Yubao Z, Lei S, Xianliang Z, Wei Z, Li S, Hao W, Jianjun L, Detrano R, Rutai H. Prevalence of chronic rheumatic heart disease in Chinese adults. Int J Cardiol. 2006;107(3):356-9.
19. Engel ME, Haileamlak A, Zühlke L, Lemmer CE, Nkepu S, van de Wall M, Daniel W, Shung King M, Mayosi BM. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. Heart. 2015;101(17):1389-94.
20. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470-6.
21. Zühlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep. 2013;15(3):343.
22. WHO Technical Report Series. Rheumatic fever and rheumatic heart disease: Report of a WHO expert panel, Geneva 29 October -1 November 2001. Geneva: WHO; 2004.